Last reviewed · How we verify
NCT07076316
Early Rehabilitation Nursing for Severe Acute Pancreatitis
NA trial testing Structured Early Rehabilitation Nursing Pathway in Acute Pancreatitis Drug-Induced in 104 participants. Completed in 31 March 2023.
31 March 2023
Quick facts
| Lead sponsor | Qiandi Huang |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 104 |
| Start date | 1 February 2021 |
| Primary completion | 31 March 2023 |
| Estimated completion | 31 March 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Structured Early Rehabilitation Nursing Pathway
- Routine Care
Conditions studied
- Acute Pancreatitis Drug-Induced — all drugs for Acute Pancreatitis Drug-Induced →
Sponsor
Qiandi Huang
Who can join
18 and older, any sex, with Acute Pancreatitis Drug-Induced. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized controlled trial evaluates the clinical efficacy of a structured early rehabilitation nursing (ERN) pathway compared to routine care in patients with severe acute pancreatitis (SAP). The study aims to determine if the ERN pathway, which includes phased mobility, respiratory training, and psychological support, can improve gastrointestinal recovery, reduce hospital stay and complications, and enhance functional independence and quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07076316
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07076316 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Qiandi Huang
- Last refreshed: 22 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07076316.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing